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During an 11 month prospective study of stool samples submitted for ova and parasites, we identified ten cases of cryptosporidiosis in children, five in one family. The diagnosis was made by finding Cryptosporidium oocysts in stool samples which were processed by formalin-ether concentration, examined by direct wet mount and confirmed by modified cold Kinyoun stain. During the study, ten cases of Giardia lamblia were also diagnosed making cryptosporidial infection as common as giardiasis in the pediatric population studied. One child had coinfection with Giardia and Cryptosporidium.
The childrenwith cryptosporidiosis ranged in age from eight months to 5 years and there was an equal number of males and females. The majority of children were in some form of day care program. Family history was positive for diarrheal illness in each case of cryptosporidiosis. Symptoms and signs were variable and included acute and chronic diarrhea, anorexia, vomiting, abdominal pain and weight loss. No child was found to be immunocompromised or immunodeficient.
We conclude that cryptosporidiosis is more common in children than previously thought and should be considered in the differential diagnosis of children with diarrhea. Stools examined for ova and parasites should be routinely examined for Cryptosporidium. Cutaneous ieishmaniasls i s t r a n s m i t t e d by t h e phlebotomus sandfly which i n j e c t s t h e promastigate form o f t h e p a r a s i t e (Leishmania t r o p i c a major) i n t o t h e skin. The organisms a r e t a k e n up by t h e s k i n macrophages and w i t h i n t h e s e c e l i s Transform i n t o amastigotes and a c h r o n i c nononuclear c e l l inflammatory response occurs. Although T -c e l l iyrnphokines and i n t e r f e r o n s have been shown t o be e f f e c t i v e inducers o f leishmaniacidal c a p a c i t y o f manocytes i n v i t r o , i t i s unclear why t h e course of t h e inflammation i s s o prolonged i n vivo. Therefore, we have perfonned immunohistoiogical a n a l y s i s o f t h e l e s i o n s i n t e n p a t i e n t s w i t h cutaneous leishmaniasis. D i a g n o s i s was confirmed by a p p r o p r i a t e c l i n i c a l h i d t o r y and appearance, c u l t u r e of p a r a s i t e s from t h e l e s i o n and/or i d e n t i f i c at i o n o f amastigotes i n a biopsy specirnen o f t h e lesion. Using t h e technique o f e i t h e r immunof i uorascnce w i t h t h e OKT s e r i e s o f a n t i b o d i e s o r immunoperoxidase s t a i n i n s w i t h t h e Leu s e r i e s o f antibodies, we found t h a t t h e T suppressor lymphocyte was t h e predominant c e l l i n t h e mononuclear c e l l i n f i l t r a t e (Om3/ Leui.4 -80 L 7%;OKT4/Leu3a -10 L 8%; OKT8/Leu 2 a -57 + 5 9 ) . These p a t i e n t s wore not immunocompromised, had normal c e l l u l a r immune f u n c t i o n s and had developed s p e c i f i c c e l l u l a r immunity t o t h e i n f e c t i n g parasite, Leishmania t r a p i c a major ( S t i n u i a t i o n index range 2.51 L 0.42 t o 5.03 5 . 2 6 ; "on-immune c o n t r o l s < 1 ) . These f i n d i n g s support t h e c o n t e n t i o n t h a t i n p a t i e n t s w i t h cutaneous lelshrnaniasls i n a p p r o p r i a t e s e n s i t i s a t i o n o f T suppressor lymphocytes occurs, which may by i n h i b i t i n g t h e p o s i t i v e inducer s i g n a l s o f T-helper lymphocytes account f o r t h e c h r o n i c i t y o f t h e s e iasions. Neonatal HSV infection is usually acquired at birth but a few reports have implied intrauterine infection. Of 155 cases of neonatal herpes, 13 (8.4%) had evidence of HSV acquisition prior to labor. Clinical manifestations defined two groups: 8 babies with early evidence of infection and 5 with late in utero acquisition. Of the 8 infants, all were premature. Manifestations included skin lesions/scars at birth (5/8), chorioretinitis (2/4), microphthalmia (3/7), microcephaly (5/8), and other CNS abnormalities on CT scan (618). Two infants died; the 6 surviving had severe neurologic sequelae. Four mothers had a history of primary genital HSV infection between 6-16 weeks. Signs of infection in the latter group were skin lesions at birth (5/5), hepatosplenomegaly (3/5), and other organ involvement (315). Two were prematures. One died from HSV pneumonia while the other 4 had no documented CNS sequelae. For this group, rupture of membranes >4 hours occurred in 1 case. Only 1 mother had a history of genital HSV infection (28 weeks) but 3 fathers of other babies reported genital lesions. Other etiologies for congenital infection were excluded. These findings indicate transmission of HSV can occur at any time during gestation. Although skin lesions are the hallmark of infection, regardless of time of acquisition, surviving newborns of early in utero infection are likely to have severe neurologic sequelae. 
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CHARACTERIZATION OF THE INFANT'S ANTIBODY RESPONSE
R e p e t i t i v e imnunization (imm) with vaccines (vax) composed of H. influenzae b capsular polysaccharide (PRP) oligomers coupled
to diphtheria toxoid (DTd), designated DTd-01, induces anti-PRP antibody (Ab) with booster responses in infants at ages at which there is no response to PRP vax. To further examine the Ab response of infants 2-30 mo-old to imm with DTd-01, the isotype, IgG subclass distribution, and IgG diversity of Ab were analyzed by enzyme immunoassay with monoclonal subclass-specific Ab using human hybridoma Abs as standards and by analytical isoelectric focusing (IEF). Ab of the IgG isotype predominated and was preferentially boosted in sera of the highest responders of 2-6 moold infants imm with DTd-01. Ab of both the IgG and IgG2 subclass were detected after imm with DTd-01, but tiere was a predominate IgGl subclass Ab response in 13/14 infants. In contrast, imm with PRP vax induced a predominate IgG2 subclass response in 4/7 infants, 24 mo-old, and 3/7 children, 48-55 mo-old. The IEF Ab spectrotypes had a pI of 8.5-9.5 and showed restricted diversity with usually an increase after booster imm of the same clonotype that was induced by the lo imm. These results suggest that imm with DTd-01 is inducing predominately an IgGl restricted Ab response from clones that are reactivated following repeat imm, without other clonal recruitment, and may be activating a different B cell subset than is activated by imm with PRP. and levela and Metropol i t a n General ~o s~i t a i , ~i eve1 and.
A s a f e t y and immunogenicity study o f the Oka/Merck l i v e attenuated v a r i c e l l a vaccine was conducted among 51 h e a l t h y c h i l d r e n 12-24 months, w i t h a negative c l i n i c a l h i s t o r y o f v a r i c e l l a . Parents maintained a d e t a i l e d medical d i a r y f o r 6 weeks f o l l o w i n g immunization, and a l l c h i l d r e n w i t h f e v e r o r rash were seen by a physician. 11 c h i l d r e n had f e v e r . 38 C d u r i n g the 6 week follow-up period, i n c l u d i n g 3 c h i l d r e n w i t h documented b a c t e r i a l i n f e c t i o n s . 3 c h i l d r e n i n t h e 1 s t week and 6 i n t h e 3rd-4th week developed non-specific maculopapular rashes. Only one c h i l d had s w e l l i n g and p a i n a t t h e i n j e c t i o n s i t e .
Pre-immunization and 6 week post-immunization sera were t i t e r e d simultaneously by an i n d i r e c t f l u o r e s c e n t antibody t e s t which detects antibody t o membrane antigen (modified FAMA). 48 of 51 c h i l d r e n (94.1%) demonstrated sero-conversion w i t h a , 4 f o l d r i s e i n antibody t i t e r . Sero-conversion was l e s s i n 12-15 month o l d infants (14/16, 87.5%) than i n 15-24 month 01 d i n f a n t s (34135, 97.1%). Geometric mean t i t e r s (expressed as t h e r e c i p r o c a l of t h e mean) were n o t r e l a t e d t o age: 12-15 months, 57.4 ( n = 14); 15-18 months, 35.3 ( n -8); 18-21 months, 43.9 ( n = 111, and 21-24 months, 44.5 ( n = 15). Oka/Merck v a r i c e l l a vaccine appears safe and immunogenic i n c h i l d r e n 12-24 months. Further study i s i n d i c a t e d t o determine t h e ootimal age f o r vaccination.
